<p><h1>Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Market Provides Detailed Segmentation of this Market based on Type, Application, and Region and Forecast for the Period from 2024 - 2031</h1></p><p><strong>Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Market Analysis and Latest Trends</strong></p>
<p><p>The Cancer Genomic Testing Market is experiencing significant growth as advances in genomics and personalized medicine enhance cancer diagnostics and treatment options. During the forecast period from 2022 to 2028, the market is expected to grow at a CAGR of 5.4%. Factors contributing to this growth include the increasing prevalence of cancer globally, rising investments in cancer research, and the adoption of targeted therapies based on genetic profiling.</p><p>One notable trend is the growing demand for liquid biopsy tests, which enable non-invasive cancer detection and monitoring by analyzing circulating tumor DNA in the bloodstream. The integration of artificial intelligence and machine learning in genomic data analysis is also reshaping the landscape, improving accuracy and efficiency in test outcomes. Further, rising awareness about the benefits of genomic testing among healthcare providers and patients is propelling market expansion.</p><p>Geographically, North America remains a dominant player due to advanced healthcare infrastructure and high adoption of innovative technologies, while emerging markets are witnessing rapid development in genomic testing capabilities. Overall, the Cancer Genomic Testing Market presents promising opportunities as stakeholders continue to innovate and improve cancer care.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliablemarketsize.com/enquiry/request-sample/1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">https://www.reliablemarketsize.com/enquiry/request-sample/1068349</a></p>
<p>&nbsp;</p>
<p><strong>Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Major Market Players</strong></p>
<p><p>The global cancer genomic testing market is rapidly evolving, driven by advancements in genomic technology and increasing cancer incidence rates. Key players in this space include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Agilent Technologies, and Thermo Fisher Scientific.</p><p>Myriad Genetics leads in hereditary cancer testing, particularly with its MYRisk panel, which tests for multiple hereditary cancer syndromes. The company reported revenues of approximately $900 million in 2022, reflecting robust demand for its comprehensive testing solutions. Future growth is anticipated as more healthcare providers adopt personalized medicine.</p><p>Illumina, a leader in sequencing technologies, also plays a pivotal role in the cancer genomic testing market with products designed for high-throughput genomic analysis. The company generated revenues exceeding $4 billion in 2022. Illuminaâ€™s focus on improving accessibility and reducing costs for genomic sequencing positions it favorably for future growth, expected to reach a CAGR of over 10% through 2028.</p><p>LabCorp offers a range of diagnostic services, including comprehensive cancer genomic tests, and reported revenues around $3.5 billion in 2022. It is well-positioned to capitalize on the growing need for precision medicine tailored to cancer treatment.</p><p>Quest Diagnostics is another significant player, leveraging its extensive network to deliver genetic testing services. The company achieved revenues of about $8 billion in 2022, demonstrating strong demand across its diagnostic offerings, including oncology.</p><p>The competitive landscape for cancer genomic testing is characterized by rapid technological advancements, increasing focus on precision medicine, and strategic partnerships to enhance market reach. Overall, the market is expected to continue its growth trajectory, driven by innovations in testing methodologies and rising patient awareness.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Manufacturers?</strong></p>
<p><p>The global Cancer Genomic Testing Market is poised for significant growth from 2022 to 2028, driven by advancements in precision medicine, increasing cancer prevalence, and technological innovations in genomics. The market is expected to expand at a robust CAGR, propelled by rising investments in research and development and growing adoption of personalized treatment plans. Key players are focusing on enhancing testing capabilities and expanding their service offerings. Furthermore, regulatory support and increasing awareness about genomic testing among healthcare providers and patients are expected to further boost market dynamics, establishing a promising future outlook.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliablemarketsize.com/enquiry/pre-order-enquiry/1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">https://www.reliablemarketsize.com/enquiry/pre-order-enquiry/1068349</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Breast Cancer Genomic Testing</li><li>Lung Cancer Genomic Testing</li><li>Blood Cancer Genomic Testing</li><li>Liver Cancer Genomic Testing</li><li>Stomach Cancer Genomic Testing</li><li>Others</li></ul></p>
<p><p>The cancer genomic testing market is experiencing significant growth, projected to expand from 2022 to 2028. It encompasses various cancer types, including breast, lung, blood, liver, and stomach cancers, along with other cancers. Advances in genomic technologies are driving demand for personalized treatment options, enhancing early detection and better therapeutic outcomes. Regions with robust healthcare infrastructures are likely to lead market growth, fueled by increasing awareness, rising incidences of cancers, and enhanced research and development efforts in genomics.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliablemarketsize.com/purchase/1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">https://www.reliablemarketsize.com/purchase/1068349</a></p>
<p>&nbsp;</p>
<p><strong>The Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Clinics</li><li>Diagnostic Laboratories</li><li>Academic and Research Institutes</li><li>Others</li></ul></p>
<p><p>The global cancer genomic testing market is projected to grow significantly from 2022 to 2028, driven by advancements in precision medicine and personalized therapies. Key applications include hospitals and clinics that utilize genomic testing for tailored treatment plans, diagnostic laboratories that conduct comprehensive testing for cancer markers, and academic and research institutes focused on cancer genomics studies. This market's expansion is fueled by increasing cancer incidence, rising awareness of genomic testing benefits, and technological innovations in genomic analysis.</p></p>
<p><a href="https://www.reliablemarketsize.com/cancer-genomic-testing-market-in-global-r1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">&nbsp;https://www.reliablemarketsize.com/cancer-genomic-testing-market-in-global-r1068349</a></p>
<p><strong>In terms of Region, the Cancer Genomic Testing Market, Global Outlook and Forecast 2022-2028 Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global cancer genomic testing market is projected to experience significant growth from 2022 to 2028, driven by rising cancer incidences and advancements in genomics. North America is expected to dominate the market, holding approximately 40% market share, followed by Europe at around 30%. The Asia-Pacific region, led by China, is anticipated to capture nearly 20% of the market, while other regions will account for the remaining 10%. This landscape indicates a robust expansion trajectory across diverse markets.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliablemarketsize.com/purchase/1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">https://www.reliablemarketsize.com/purchase/1068349</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliablemarketsize.com/enquiry/request-sample/1068349?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">https://www.reliablemarketsize.com/enquiry/request-sample/1068349</a></p>
<p><strong></strong></p>
<p><p><a href="https://www.linkedin.com/pulse/in-depth-first-aid-market-review-size-share-51cagr-growth-analysis-zxt4e?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">First Aid Market</a></p><p><a href="https://github.com/CliffMedina6/Market-Research-Report-List-6/blob/main/anti-decubitus-dynamic-mattresses-market.md?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">Anti-decubitus Dynamic Mattresses Market</a></p><p><a href="https://www.linkedin.com/pulse/semiconductor-diffusion-furnace-market-share-analysis-growth-25hqe?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">Semiconductor Diffusion Furnace Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/double-acting-hydraulic-intensifier_b70e36a0d6de39?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">Double-acting Hydraulic Intensifier Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/pneumatic-paper-waste-stripper-mark_bcd16e464965c3?utm_campaign=1131&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=29102024&utm_id=cancer-genomic-testing-market-global-outlook-and-forecast-2022-2028">Pneumatic Paper Waste Stripper Market</a></p></p>